These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25064545)

  • 1. Multiple liver lesions in a patient with positive hepatitis C serology and elevated AFP: is it HCC?
    Dwyer JP; Hosking P; Lubel J
    Gastroenterology; 2014 Sep; 147(3):e12-3. PubMed ID: 25064545
    [No Abstract]   [Full Text] [Related]  

  • 2. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tumor markers and hepatitis markers profile in liver tumors.
    Khalifa A; Mady EA; Abadeer N; Kamal A
    Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
    Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
    J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core antigen testing in the monitoring of patients on dialysis.
    Li Cavoli G; Zagarrigo C; Schillaci O; Tralongo A; Rotolo U
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1056-8. PubMed ID: 22982924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early diagnosis of acute hepatitis C--detection of anti-HCV antibody and HCV-RNA].
    Yoshizawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):353-6. PubMed ID: 15359820
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of plasma osteopontin level in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    El-Din Bessa SS; Elwan NM; Suliman GA; El-Shourbagy SH
    Arch Med Res; 2010 Oct; 41(7):541-7. PubMed ID: 21167394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of liver diseases using serum biomarkers.
    Cujic D; Golubovic S; Bojic-Trbojevic Z; Ilic N; Baricevic I; Nedic O
    J BUON; 2010; 15(1):141-6. PubMed ID: 20414942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of hepatitis C diagnosis].
    Echevarría JM; León P
    Enferm Infecc Microbiol Clin; 1995; 13(7):387-9. PubMed ID: 8519814
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis between asymptomatic HCV carriers and previously infected patients with anti-HCV antibody in general clinic setting].
    Yasuda K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):391-5. PubMed ID: 15359828
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels.
    Bertino G; Ardiri AM; Santonocito MM; Boemi PM
    Panminerva Med; 2009 Jun; 51(2):133-4. PubMed ID: 19776714
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?
    Mohran ZY; Ali-Eldin FA; Abdel Aal HA
    Arab J Gastroenterol; 2011 Mar; 12(1):29-33. PubMed ID: 21429452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.